INSM•benzinga•
Insmed Presents Patient-Reported Outcomes And Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE In Patients With NTM Lung Disease Caused By MAC At American Thoracic Society 2024 International Conference Plenary Session
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 20, 2024 by benzinga